NCT07309692 Different Modalities for the Evaluation of Patients With Peri-menopausal Bleeding
| NCT ID | NCT07309692 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Perimenopausal Bleeding |
| Study Type | INTERVENTIONAL |
| Enrollment | 106 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 106 participants in total. It began in 2025-12-01 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to compare between 3D ultrasonography and hysteroscopy for the evaluation of cases with Peri-menopausal bleeding
Eligibility Criteria
Inclusion Criteria: Any pattern of abnormal uterine bleeding as menorrhagia or metrorrhagia for more than 3 months at age between 40 and 55 years , and no ovarian lesion or local cause of bleeding as vaginal or cervical ulcer Exclusion Criteria: * • Women with postmenopausal bleeding. * Systemic causes of perimenopausal bleeding DM Hypertension or chronic liver disease. * Women on hormonal therapy or using any contraception as IUD. * Women have contraindication for hysteroscopy as cervical stenosis or pregnancy.
Contact & Investigator
ahmed abdelrahem fattouh, resident of Obstetrics and Gyn
✉ ahmedalatoon04@gmail.com📞 00201146329946
Frequently Asked Questions
Who can join the NCT07309692 clinical trial?
This trial is open to female participants only, aged 40 Years or older, up to 55 Years, studying Perimenopausal Bleeding. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07309692 currently recruiting?
Yes, NCT07309692 is actively recruiting participants. Contact the research team at ahmedalatoon04@gmail.com for enrollment information.
Where is the NCT07309692 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07309692 clinical trial?
NCT07309692 is sponsored by Sohag University. The trial plans to enroll 106 participants.